0001104659-23-119091.txt : 20231116 0001104659-23-119091.hdr.sgml : 20231116 20231116160517 ACCESSION NUMBER: 0001104659-23-119091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231114 FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Hunter C CENTRAL INDEX KEY: 0001636385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 231414598 MAIL ADDRESS: STREET 1: C/O GENESEE & WYOMING INC. STREET 2: 20 WEST AVENUE CITY: DARIEN STATE: CT ZIP: 06820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 tm2330902-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-11-14 0 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001636385 Smith Hunter C 222 BERKELEY STREET, 12TH FLOOR BOSTON MA 02116 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-11-14 4 M 0 12000 6.88 A 73406 D Common Stock 2023-11-14 4 S 0 12000 30.3811 D 61406 D Stock Option (Right to Buy) 6.88 2023-11-14 4 M 0 12000 0 D 2027-08-08 Common Stock 12000 149094 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $30.00 to $30.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock options is fully vested. /s/ Hunter Smith 2023-11-16